Document Detail

Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke.
MedLine Citation:
PMID:  21054779     Owner:  NLM     Status:  In-Data-Review    
Summary.  Background: Compared with coronary artery disease, there are few studies on von Willebrand factor (VWF) in ischemic stroke (IS). Moreover, there is little information on VWF in the etiologic subtypes of IS. Objectives: The aim of the present study was to investigate VWF in IS and in the etiologic subtypes of IS. Patients/methods: The Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) is a case-control study comprising 600 patients and 600 matched controls. Etiologic IS subtype was defined according to the TOAST criteria. Blood sampling was performed in the acute phase and after 3 months. Results: The levels of VWF were increased in overall IS, at both time-points. The 3-month VWF levels were increased in the subtypes of large-vessel disease (LVD), cardioembolic (CE) stroke and cryptogenic stroke, but not in the subtype of small-vessel disease (SVD), as compared with the controls. The acute phase VWF levels were significantly increased in all four subtypes. In the multivariate regression analysis, with vascular risk factors as covariates, the 3-month VWF levels were associated with CE stroke and cryptogenic stroke, and the acute phase VWF levels with all subtypes. There were significant subtype-specific differences in VWF, with the highest levels in LVD and CE stroke. Conclusions: The present results show that VWF levels are increased in patients with IS. Furthermore, the VWF levels differ between etiologic IS subtypes and thus, it is important to consider etiologic subtypes in future studies of VWF in patients with IS.
E Hanson; K Jood; S Karlsson; S Nilsson; C Blomstrand; C Jern
Related Documents :
16793719 - The relationship between mean platelet volume, stroke subtype and clinical outcome.
12154259 - Prevalence and predictors of upper airway obstruction in the first 24 hours after acute...
21505449 - Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q de...
9208259 - Cerebrovascular disease as the initial clinical presentation of haematological disorders.
8131429 - Videofluoroscopic evidence of aspiration predicts pneumonia and death but not dehydrati...
16490939 - Quantitative assessment of recovery from motor hemineglect in acute stroke patients.
3137179 - Tracking patient demographics and disease categories in a primary care residency.
7377939 - Nerve conduction studies in patients with cervical spinal cord injuries.
23607529 - Disease-modifying anti-rheumatic drugs for refractory severe knee synovitis in patients...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  9     ISSN:  1538-7836     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  England    
Other Details:
Languages:  eng     Pagination:  275-81     Citation Subset:  IM    
Copyright Information:
© 2011 International Society on Thrombosis and Haemostasis.
Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, the Sahlgrenska Academy at University of Gothenburg, Gothenburg Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg Department of Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Decrease in serum adiponectin levels in response to treatment predicts good prognosis in acute decom...
Next Document:  Yeasts as a model for human diseases.